Summary
Rocket Lab Corp (RKLB) reported significant revenue growth in its Q3 2022 10-Q filing, driven by a substantial increase in both launch services and space systems revenue. This growth was largely fueled by recent acquisitions and a higher launch cadence for its Electron rocket. Despite the impressive revenue top-line expansion, the company continued to operate at a net loss, although the loss narrowed significantly compared to the prior year's quarter on a non-GAAP basis, partly due to the absence of a significant one-time warrant revaluation charge. The company is strategically expanding its capabilities with the development of the Neutron launch vehicle and continued integration of acquired space systems businesses. Management indicates confidence in its liquidity, projecting existing cash and cash equivalents to be sufficient for at least the next twelve months, though future capital requirements for expansion and new product development may necessitate additional financing. Investors should note the ongoing investments in R&D and SG&A, which are expected to decline as a percentage of revenue over time.
Financial Highlights
53 data points| Revenue | $63.06M |
| Cost of Revenue | $54.59M |
| Gross Profit | $8.47M |
| R&D Expenses | $17.51M |
| SG&A Expenses | $22.96M |
| Operating Expenses | $40.47M |
| Operating Income | -$32.00M |
| Net Income | -$34.61M |
| EPS (Basic) | $-0.07 |
| EPS (Diluted) | $-0.07 |
| Shares Outstanding (Basic) | 469.77M |
| Shares Outstanding (Diluted) | 469.77M |
Key Highlights
- 1Revenue surged by 1,093% year-over-year to $63.1 million for Q3 2022, primarily driven by acquisitions and increased launch cadence.
- 2Space Systems revenue grew significantly by 862% to $40.1 million, with $30.6 million attributed to recent acquisitions.
- 3Launch Services revenue increased by 1,947% to $23.0 million, due to a higher number of launch missions compared to the prior year.
- 4Net loss for the quarter decreased to $34.6 million from $88.0 million in Q3 2021, benefiting from the absence of a large warrant revaluation charge from the prior year.
- 5Total backlog stood at $520.6 million as of September 30, 2022, with approximately 42% expected to be recognized within the next 12 months.
- 6Cash and cash equivalents and marketable securities totaled $512.5 million as of September 30, 2022, providing a healthy liquidity position.
- 7The company is making significant investments in Research and Development, particularly for the Neutron launch vehicle, with R&D expenses increasing by 23% year-over-year for the quarter.